T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWNC
1151
DELISTED
Southwestern Energy Company
SWNC
| $18.7M | ﹤0.01% |
+374,050
| New | +$20.2M |
|
|
PHX
1152
DELISTED
PHX Minerals
PHX
| $18.7M | ﹤0.01% |
944,870
+4,600
| +0.5% | +$95.8K |
|
1153
Travel + Leisure Co
TNL
$4.58B
| $18.6M | ﹤0.01% |
456,467
+2,381
| +0.5% | +$94.8K |
|
|
CTXS
1154
DELISTED
Citrix Systems Inc
CTXS
| $18.6M | ﹤0.01% |
366,132
+24,613
| +7% | +$1.21M |
|
1155
Euronet Worldwide
EEFT
$2.78B
| $18.5M | ﹤0.01% |
314,650
+8,100
| +3% | +$429K |
|
1156
Portland General Electric
POR
$5.92B
| $18.5M | ﹤0.01% |
497,520
+468,120
| +1,592% | +$17.7M |
|
|
RYZ
1157
Ryerson Holding Corp
RYZ
$1.5B
| $18.4M | ﹤0.01% |
2,894,020
+31,290
| +1% | +$212K |
|
1158
Best Buy
BBY
$18B
| $18.4M | ﹤0.01% |
487,319
+35,700
| +8% | +$1.37M |
|
|
EIGR
1159
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $18.4M | ﹤0.01% |
2,160
-294
| -12% | -$2.57M |
|
|
CAA
1160
DELISTED
CalAtlantic Group, Inc.
CAA
| $18.3M | ﹤0.01% |
405,696
+3,046
| +0.8% | +$121K |
|
|
CADE
1161
DELISTED
Cadence Bank
CADE
| $18.1M | ﹤0.01% |
781,585
+14,990
| +2% | +$327K |
|
|
PRXL
1162
DELISTED
Parexel International Corp
PRXL
| $18.1M | ﹤0.01% |
262,007
+20,400
| +8% | +$1.3M |
|
1163
Kopin
KOPN
$898M
| $18.1M | ﹤0.01% |
5,132,766
+6,320
| +0.1% | +$24.4K |
|
1164
Travere Therapeutics
TVTX
$5.79B
| $17.9M | ﹤0.01% |
+747,200
| New | +$11.4M |
|
1165
NetApp
NTAP
$40.2B
| $17.9M | ﹤0.01% |
504,802
-830
| -0.2% | -$31.7K |
|
|
ESIO
1166
DELISTED
Electro Scientific Industries
ESIO
| $17.9M | ﹤0.01% |
2,896,360
+14,200
| +0.5% | +$95.9K |
|
1167
Eastman Chemical
EMN
$8.43B
| $17.9M | ﹤0.01% |
257,814
+1,800
| +0.7% | +$130K |
|
1168
Weyco Group
WEYS
$437M
| $17.8M | ﹤0.01% |
595,888
-83,732
| -12% | -$2.34M |
|
1169
Oneok
OKE
$58.4B
| $17.8M | ﹤0.01% |
368,870
+10,110
| +3% | +$462K |
|
|
LLL
1170
DELISTED
L3 Technologies, Inc.
LLL
| $17.8M | ﹤0.01% |
141,414
-2,010
| -1% | -$256K |
|
1171
Prestige Consumer Healthcare
PBH
$2.43B
| $17.8M | ﹤0.01% |
414,400
+16,200
| +4% | +$617K |
|
|
PLG
1172
Platinum Group Metals
PLG
$189M
| $17.8M | ﹤0.01% |
326,230
-4,498
| -1% | -$227K |
|
1173
Ameren
AEE
$30.2B
| $17.7M | ﹤0.01% |
420,414
+2,395
| +0.6% | +$104K |
|
|
AZPN
1174
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $17.7M | ﹤0.01% |
459,291
-13,015
| -3% | -$501K |
|
1175
Waters Corp
WAT
$40.6B
| $17.6M | ﹤0.01% |
141,366
-1,400
| -1% | -$167K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.